🔗 Permalink

Inventor profile of:

Michael L. Mitchell

City:

Hayward, California

Country:

United States

Published Applications:

Last publication date:

2017-02-02

Top Assignees for applications by Michael L. Mitchell

The entities that hold a legal rights for patent applications filed by inventor Mitchell Michael L.:

Gilead Sciences, Inc. 14 Foster City, CA United States
Korea Research Institute of Chemical Technology 6 Daejeon, South Korea
GILEAD PHARMASSET LLC 3 Foster City, CA United States
Korean Research Institute of Chemical Technology 1 Daejeon, South Korea
Korea Research Insitute of Chemical Technology 1 Daejeon, South Korea

Recent patent applications by Mitchell Michael L.

Michael L. Mitchell from Hayward, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-02-02

US20170029408A1

Chemistry; metallurgy

Antiviral compounds

#2 | 2014-09-04

US20140249074A1

Human necessities

Antiviral compounds

#3 | 2014-02-20

US20140051656A1

Chemistry; metallurgy

Antiviral compounds

#4 | 2014-02-13

US20140045818A1

Chemistry; metallurgy

Benzothiazole compounds and their pharmaceutical use

#5 | 2013-10-24

US20130281434A1

Chemistry; metallurgy

Therapeutic compounds

#6 | 2013-10-24

US20130281433A1

Chemistry; metallurgy

Therapeutic compounds

#7 | 2013-08-15

US20130210801A1

Chemistry; metallurgy

2-quinolinyl-acetic acid derivatives as HIV antiviral compounds

#8 | 2013-08-08

US20130203727A1

Chemistry; metallurgy

Naphth-2-ylacetic acid derivatives to treat AIDS

#9 | 2013-05-30

US20130137877A1

Chemistry; metallurgy

Antiviral compounds

#10 | 2013-03-28

US20130078256A1

Human necessities

NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS

#11 | 2011-07-28

US20110184029A1

Chemistry; metallurgy

PYRIDONE DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

#12 | 2011-05-26

US20110123493A1

Chemistry; metallurgy

2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections

#13 | 2011-03-31

US20110076276A1

Human necessities

Pyrimidine derivatives as HIV reverse transcriptase inhibitors

#14 | 2010-02-11

US20100034827A1

Chemistry; metallurgy

NOVEL HIV REVERSE TRANSCRIPTASE INHIBITORS

#15 | 2009-12-10

US20090306112A1

Chemistry; metallurgy

ANTIVIRAL PROTEASE INHIBITORS

#16 | 2009-06-25

US20090163712A1

Chemistry; metallurgy

Processes for preparing HIV reverse transcriptase inhibitors

#17 | 2009-04-23

US20090105279A1

Chemistry; metallurgy

Antiviral protease inhibitors

#18 | 2009-04-16

US20090099096A1

Chemistry; metallurgy

AZA-peptide protease inhibitors

#19 | 2009-03-19

US20090075939A1

Chemistry; metallurgy

HIV reverse transcriptase inhibitors

#20 | 2008-03-20

US20080070920A1

Chemistry; metallurgy

Pyrimidine-2,4-dione HIV reverse transcriptase inhibitors

#21 | 2007-01-11

US20070010489A1

Human necessities

Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds

InventorID:

165141 ⎘